Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
---|
05/10/2002 | WO2002036583A1 Pgd2 receptor antagonistic pharmaceutical compositions |
05/10/2002 | WO2002036565A1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them |
05/10/2002 | WO2002036555A1 Sulfamides as gamma-secretase inhibitors |
05/10/2002 | WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
05/10/2002 | WO2002018364A3 Process for preparing 2-phenyl-3-aminobenzothiophenes |
05/10/2002 | WO2002016338A8 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
05/10/2002 | WO2001024827A3 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
05/10/2002 | CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
05/09/2002 | US20020055643 Tubulin binding ligands and corresponding prodrug constructs |
05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
05/09/2002 | US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
05/08/2002 | EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors |
05/08/2002 | EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
05/08/2002 | EP1202968A2 Antibacterial agents |
05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
05/08/2002 | EP1202726A2 Method for treating chronic pain using mek inhibitors |
05/08/2002 | DE10054482A1 Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them |
05/08/2002 | CN1348459A Heterocyclic metallocene compounds and use thereof in catalyst systems for producing olefin polymers |
05/08/2002 | CN1348441A N-substituted arylsulfonyl-lamino hydroxamic acids |
05/08/2002 | CN1348439A New compounds, their preparation and use |
05/07/2002 | US6384281 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
05/07/2002 | US6384080 Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase |
05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
05/07/2002 | US6384036 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
05/07/2002 | US6384035 Heterocycles useful in the treatment of benign prostatic hyperplasia |
05/07/2002 | US6384033 Drugs for vision defects |
05/07/2002 | US6383988 Thienysulfonylamino (thio) carbonyl compounds |
05/02/2002 | WO2002034741A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
05/02/2002 | WO2002034711A1 Biaryl compounds as serine protease inhibitors |
05/02/2002 | WO2001096283A3 Hiv integrase inhibitors |
05/02/2002 | WO2001064642A3 Benzamides and related inhibitors of factor xa |
05/02/2002 | WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
05/02/2002 | WO2001023375A3 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
05/02/2002 | US20020052401 Benzophenones and sulfones as inhibitors of glycine uptake |
05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
05/02/2002 | US20020052349 p-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
05/02/2002 | US20020052007 Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives |
05/02/2002 | EP1201650A2 Ionic malonitril derivatives and their uses |
05/02/2002 | EP1201648A1 Carbamate derivatives and agricultural/horticultural bactericides |
05/02/2002 | EP1200457A2 Cysteine protease inhibitors |
05/02/2002 | EP1200426A1 Substituted thiene-3-yl-sulfonyl amino(thio)carbonyl-triazolin(thi)ones |
05/02/2002 | EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
05/02/2002 | EP1200393A1 Oxime amides and hydrazone amides having fungicidal activity |
05/02/2002 | EP1200076A1 Calcilytic compounds |
05/02/2002 | EP0530338B1 Anisotropic organic compounds |
05/02/2002 | DE10049484A1 Anticonvulsant, anxiolytic and especially analgesic medicaments, comprising new or known beta-thio-alpha-aminoacid compounds having strong affinity for gabapentin binding site |
05/02/2002 | DE10049483A1 Substituierte 1-Aminobutan-3-ol-Derivate Substituted 1-aminobutan-3-ol derivatives |
05/02/2002 | DE10049481A1 Substituierte C-Cyclohexylmethylamin-Derivate C-substituted derivatives cyclohexylmethylamine |
05/02/2002 | CA2426430A1 Biaryl compounds as serine protease inhibitors |
05/02/2002 | CA2426007A1 A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
05/01/2002 | CN1347424A Metallocene compounds, process for their preparation and their use in catalytic systems for polymerization of olefins |
05/01/2002 | CN1347417A 4-oxo-4,7-dihydro-thieno [2,3-b] pyridine-5-carboxamides as antiviral agent |
05/01/2002 | CN1347406A Carbamic acid derivs. and their use as metabotropic glutamate receptor ligands |
05/01/2002 | CN1083831C Novel tricyclic compounds and drug compositions contg. same |
04/30/2002 | US6380429 Oxidation of sulfonamide |
04/30/2002 | US6380392 Complexes |
04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
04/30/2002 | US6380249 HIV integrase inhibitors |
04/30/2002 | US6380246 For combating pests and weeds |
04/30/2002 | US6380243 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and kaposi herpesvirus. |
04/30/2002 | US6380224 For therapy of eating disorders, obesity, bulimia nervosa, diabetes, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders, depression and anxiety |
04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |
04/30/2002 | US6380221 Ortho-anthranilamide derivatives as anti-coagulants |
04/30/2002 | US6380214 Thiophene-3-carboxylic acid amide derivatives |
04/30/2002 | US6380199 Treatment of attention deficit hyperactivity disorder |
04/30/2002 | CA2172114C New thiophene compounds, process for preparing the same and pharmaceutical compositions containing them |
04/25/2002 | WO2002033110A2 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
04/25/2002 | WO2002032892A1 Process for the preparation of pgd2 antagonist |
04/25/2002 | WO2002032880A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
04/25/2002 | WO2002032856A2 Insecticidal 1,8-naphthalenedicarboxamides |
04/25/2002 | WO2002032389A1 Method of treating stroke |
04/25/2002 | WO2001097810A3 Use of therapeutic benzamide derivatives |
04/25/2002 | WO2001085683A3 Pyrrolyl-, furanyl- and thienyl-substituted p-aminophenols and colorants containing said compounds |
04/25/2002 | WO2001081333A3 Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes |
04/25/2002 | US20020049344 New vitamin d derivatives with carbo-or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
04/25/2002 | US20020049288 Metal-ligand complex precursor composition of an amine containing ligand of given formula and group 3,4, or lanthanide metal compound; polymerizing alpha-olefins, higher comonomer content of C4+ olefins |
04/25/2002 | US20020049234 Inhibitors of factor Xa; for example 3-(4-tert-butylbenzoyl)amino-N-(4-methoxyphenyl)-2-thiophenecarboxamide |
04/25/2002 | US20020049226 Treating obesity, hyperlipidemia, glaucoma, arrhythmia, skin disorders, thyroid disease, hypothyroidism, diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis |
04/25/2002 | US20020049211 Combination treatment for depression and anxiety |
04/25/2002 | US20020049198 Administering to a patient having or at risk of having osteoarthritis, a therapeutically effective amount of an bicyclicaromatic or heteroaromatic compound containing amine and hydroxy groups |
04/25/2002 | US20020048687 Efficient light emission and excellent heat resistance |
04/25/2002 | CA2426594A1 Production of .alpha.-hydroxy-carboxylic acids using a coupled enzyme system |
04/25/2002 | CA2426097A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
04/25/2002 | CA2420994A1 Method of treating stroke |
04/24/2002 | EP1198172A1 Use of n-substituted heterocyclylalkylamines as herbicides and novel n-substituted thienylalkylamines |
04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
04/24/2002 | CN1346344A Substituted 2-aminobenzamide caspase ihibitors and the use thereof |
04/24/2002 | CN1346343A 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
04/24/2002 | CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
04/24/2002 | CN1083439C 2-amino-4-bicyclomino-1,3,5-triazines as herbicides and plant growth regulators |
04/23/2002 | US6376682 Antidiabetic agents; dietetics |
04/23/2002 | US6376534 Guanidine compound; side effect reduction |
04/23/2002 | US6376533 Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
04/23/2002 | US6376523 Hypotensive agents; antiinflammatory agents; endogenous vasoconstruction peptide |
04/23/2002 | US6376515 Benzamides and related inhibitors of factor Xa |
04/23/2002 | US6376502 Osteoporosis compounds |